Wells Fargo
TYRA icon

Wells Fargo’s Tyra Biosciences TYRA Stock Holding History

Wells Fargo’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.07M Buy
33,561
+21,889
+188% +$724K ﹤0.01% 4059
2026
Q1 		$447K Sell
11,672
-17,377
-60% -$563K ﹤0.01% 4240
2025
Q4 		$764K Buy
29,049
+10,579
+57% +$194K ﹤0.01% 4171
2025
Q3 		$258K Buy
18,470
+3,013
+19% +$34.4K ﹤0.01% 4783
2025
Q2 		$148K Buy
15,457
+6,104
+65% +$58K ﹤0.01% 4945
2025
Q1 		$87K Sell
9,353
-140
-1% -$1.81K ﹤0.01% 5174
2024
Q4 		$132K Buy
9,493
+3,236
+52% +$58.7K ﹤0.01% 5043
2024
Q3 		$147K Sell
6,257
-249
-4% -$5.23K ﹤0.01% 4777
2024
Q2 		$104K Buy
6,506
+1,781
+38% +$30.7K ﹤0.01% 4919
2024
Q1 		$77.5K Buy
4,725
+652
+16% +$10.7K ﹤0.01% 5044
2023
Q4 		$56.4K Buy
4,073
+843
+26% +$10.9K ﹤0.01% 5227
2023
Q3 		$44.5K Sell
3,230
-2,282
-41% -$33.8K ﹤0.01% 5241
2023
Q2 		$93.9K Buy
5,512
+3,150
+133% +$45.7K ﹤0.01% 5081
2023
Q1 		$38K Buy
+2,362
New +$28.1K ﹤0.01% 5310
2022
Q4 		– Sell
-39
Closed – – 7736
2022
Q3 		$0 Sell
39
-114
-75% -$1.04K ﹤0.01% 7391
2022
Q2 		$1K Sell
153
-2,409
-94% -$19.2K ﹤0.01% 6618
2022
Q1 		$27K Sell
2,562
-4,489
-64% -$53.3K ﹤0.01% 5913
2021
Q4 		$99K Buy
+7,051
New +$140K ﹤0.01% 5644

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
APMC
Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

Wells Fargo's TYRA Position: Q2 2026 in Review

Wells Fargo increased its Tyra Biosciences (TYRA) stake by 188% in Q2 2026, buying an estimated $724K and bringing the position to 33,561 shares worth $1.07M. The position accounts for ﹤0.01% of the portfolio, ranked #4059.

Wells Fargo first reported a position in TYRA in Q4 2021 and has held it in 18 quarters since. 168 funds tracked by Wall St. Rank hold TYRA as of Q2 2026.

  • Wells Fargo held 33,561 shares of Tyra Biosciences worth $1.07M as of Q2 2026.
  • Wells Fargo bought 21,889 Tyra Biosciences shares in Q2 2026, an estimated $724K.
  • Tyra Biosciences made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #4059 holding.
  • Wells Fargo first reported a position in Tyra Biosciences in Q4 2021 and has held it in 18 quarters since.
  • 168 funds tracked by Wall St. Rank held Tyra Biosciences as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.